UNITEDHEALTH GROUP INCORPORATED (Delaware)
Here’s whether UNITEDHEALTH GROUP INCORPORATED (Delaware) (UNH) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.
Positives: trading above the 200-day MA (long-term uptrend intact); 50-day MA is rising (+1.23% over 10 days); RSI 39 — healthy momentum range; strong 1-year return of +48.0%. Concerns: below the 50-day MA (medium-term momentum negative); declining volume on rally — weak conviction (0.79x 30d avg). Currently 13.0% off its 52-week high. Score: +3/7.
UNH is holding above its long-term 200-day MA ($346.94) but has slipped below the 50-day MA ($415.19), pointing to short-term weakness in an otherwise intact trend. An RSI of 39.3 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +48.0% compares to +20.4% for SPY (beat the market by 27.6%).